Comparison of the effects of repetitive low-dose and single-dose antigen challenge on airway inflammation - PubMed (original) (raw)
Comparative Study
. 2003 Apr;111(4):818-25.
doi: 10.1067/mai.2003.1346.
Affiliations
- PMID: 12704364
- DOI: 10.1067/mai.2003.1346
Comparative Study
Comparison of the effects of repetitive low-dose and single-dose antigen challenge on airway inflammation
Lin-Ying Liu et al. J Allergy Clin Immunol. 2003 Apr.
Abstract
Background: Airway allergen provocation provides a model to study allergic inflammation in relationship to pulmonary physiology. Allergen provocation is usually administered as a relatively large single-dose challenge that might not reflect a chronic, natural, low-dose airborne allergen exposure.
Objective: We sought to compare the magnitude, characteristic features, and kinetics of airway inflammation induced by means of repetitive low-dose antigen challenges with those factors induced by means of an equivalent single-dose allergen challenge in allergic asthma.
Methods: This was a 2-period crossover study. During separate phases, each subject was administered either a predetermined single-dose antigen challenge or 25% of that dose on each of 4 consecutive days. The airway response to allergen challenge was determined by means of measurement of pulmonary function and sputum features of inflammation, including eosinophil, eosinophil-derived neurotoxin, and fibronectin levels.
Results: Both models of antigen challenge caused significant and equivalent sputum eosinophilia. The immediate decrease in FEV(1) and the FEV(1)/forced vital capacity ratio and the increase in sputum eosinophilia, eosinophil-derived neurotoxin, and fibronectin levels occurred gradually over the first 3 low doses and then reached a plateau or tended to decrease with the fourth antigen exposure.
Conclusion: Our data suggest that although the 2 challenge models had similar quantitative effects on lung function and sputum eosinophilia, the qualitative responses and kinetics of these changes were distinct. Repetitive low doses of antigen, as might mimic natural allergy exposure, produced an equivalent inflammatory response to the large single-dose challenge but with a smaller amount of antigen, suggesting that priming and accumulative effects might have occurred. Moreover, our limited data also suggest that immunologic tolerance might be induced by frequent challenges.
Similar articles
- Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
Parameswaran K, Inman MD, Watson RM, Morris MM, Efthimiadis A, Ventresca PG, Lam R, O'Byrne PM, Hargreave FE. Parameswaran K, et al. Can Respir J. 2000 Jul-Aug;7(4):313-9. doi: 10.1155/2000/254213. Can Respir J. 2000. PMID: 10980457 Clinical Trial. - Relationship between cutaneous allergen response and airway allergen-induced eosinophilia.
Boulay ME, Lemieux MC, Deschesnes F, Boulet LP. Boulay ME, et al. Allergy. 2003 Sep;58(9):945-9. doi: 10.1034/j.1398-9995.2003.00260.x. Allergy. 2003. PMID: 12911426 - Magnitude of late asthmatic response to allergen in relation to baseline and allergen-induced sputum eosinophilia in mild asthmatic patients.
Dente FL, Bacci E, Bartoli ML, Cianchetti S, Di Franco A, Costa F, Vagaggini B, Paggiaro PL. Dente FL, et al. Ann Allergy Asthma Immunol. 2008 May;100(5):457-62. doi: 10.1016/S1081-1206(10)60471-1. Ann Allergy Asthma Immunol. 2008. PMID: 18517078 - Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge.
Inman MD, Watson RM, Rerecich T, Gauvreau GM, Lutsky BN, Stryszak P, O'Byrne PM. Inman MD, et al. Am J Respir Crit Care Med. 2001 Aug 15;164(4):569-74. doi: 10.1164/ajrccm.164.4.2007063. Am J Respir Crit Care Med. 2001. PMID: 11520717 Clinical Trial. - Ozone exposure increases eosinophilic airway response induced by previous allergen challenge.
Vagaggini B, Taccola M, Cianchetti S, Carnevali S, Bartoli ML, Bacci E, Dente FL, Di Franco A, Giannini D, Paggiaro PL. Vagaggini B, et al. Am J Respir Crit Care Med. 2002 Oct 15;166(8):1073-7. doi: 10.1164/rccm.2201013. Am J Respir Crit Care Med. 2002. PMID: 12379550 Clinical Trial.
Cited by
- High- and low-dose allergen challenges in asthmatic patients using inhaled corticosteroids.
Lee WY, Southworth T, Booth S, Singh D. Lee WY, et al. Br J Clin Pharmacol. 2015 Mar;79(3):523-32. doi: 10.1111/bcp.12508. Br J Clin Pharmacol. 2015. PMID: 25214200 Free PMC article. - Airway responses and inflammation in subjects with asthma after four days of repeated high-single-dose allergen challenge.
Schulze J, Voss S, Zissler U, Rose MA, Zielen S, Schubert R. Schulze J, et al. Respir Res. 2012 Sep 19;13(1):78. doi: 10.1186/1465-9921-13-78. Respir Res. 2012. PMID: 22989372 Free PMC article. Clinical Trial. - Neural circuitry underlying the interaction between emotion and asthma symptom exacerbation.
Rosenkranz MA, Busse WW, Johnstone T, Swenson CA, Crisafi GM, Jackson MM, Bosch JA, Sheridan JF, Davidson RJ. Rosenkranz MA, et al. Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13319-24. doi: 10.1073/pnas.0504365102. Epub 2005 Sep 2. Proc Natl Acad Sci U S A. 2005. PMID: 16141324 Free PMC article. - Investigative bronchoprovocation and bronchoscopy in airway diseases.
Busse WW, Wanner A, Adams K, Reynolds HY, Castro M, Chowdhury B, Kraft M, Levine RJ, Peters SP, Sullivan EJ. Busse WW, et al. Am J Respir Crit Care Med. 2005 Oct 1;172(7):807-16. doi: 10.1164/rccm.200407-966WS. Epub 2005 Jul 14. Am J Respir Crit Care Med. 2005. PMID: 16020805 Free PMC article. Review. - High allergen exposure as a risk factor for asthma and allergic disease.
Almqvist C. Almqvist C. Clin Rev Allergy Immunol. 2005 Feb;28(1):25-41. doi: 10.1385/CRIAI:28:1:025. Clin Rev Allergy Immunol. 2005. PMID: 15834167
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical